Congressional staff and other interested parties joined a distinguished forum of judges, Members of Congress, and former U.S. public health and patent officials for a topical discussion on restoring fairness to the drug patent approval process.  Our experienced participants provided diverse perspectives on existing inequities in the application of pharmaceutical research and development incentives.  Participants also explored steps Congress could take to assure a rational and fair process that encourages the development of new medical treatments while providing access to low-cost drugs.

Opening Remarks
- Hon. Bruce A. Lehman, President, IIPI
Remarks  (PDF, 129k)

Speakers
- C. Everett Koop, Former U.S. Surgeon General
- Representative Ed Bryant (R-TN)
- Representative Jim McDermott (D-WA)
- Honorable Randall Rader, Judge, Court of Appeals for the Federal Circuit
- Honorable Ed Damich, Judge, U.S. Court of Claims
- Gerald Meyer, Former FDA Deputy Director, Center for Drug Evaluation and
  Research
- Gerald Mossinghoff, Former U.S. Patent Commissioner